Cargando…

N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

The accumulation of saturated very long-chain fatty acids (VLCFA, ≥C22:0) due to peroxisomal impairment leads to oxidative stress and neurodegeneration in X-linked adrenoleukodystrophy (ALD). Among the neural supporting cells, myelin-producing oligodendrocytes are the most sensitive to the detriment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Terluk, Marcia R., Orchard, Paul J., Cloyd, James C., Kartha, Reena V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698433/ https://www.ncbi.nlm.nih.gov/pubmed/34944641 http://dx.doi.org/10.3390/biomedicines9121826

Ejemplares similares

N-acetylcysteine Provides Cytoprotection in Murine Oligodendrocytes through Heme Oxygenase-1 Activity
por: Zhou, Jie, et al.
Publicado: (2020)

N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2023)

Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2022)

Glycosphingolipids with Very Long-Chain Fatty Acids Accumulate in Fibroblasts from Adrenoleukodystrophy Patients
por: Fujiwara, Yuko, et al.
Publicado: (2021)

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
por: Orchard, Paul J, et al.
Publicado: (2011)

The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
por: Ofman, Rob, et al.
Publicado: (2010)

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes
por: Weber, Franziska D., et al.
Publicado: (2014)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation
por: Schlüter, Agatha, et al.
Publicado: (2018)

Exogenous Addition of 25‐Hydroxycholesterol Reduces Level of Very Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy
por: Jang, Jiho, et al.
Publicado: (2019)

Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy
por: Rattay, Tim W., et al.
Publicado: (2020)

Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy
por: Natarajan, Archana, et al.
Publicado: (2021)

Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy
por: Schönfeld, Peter, et al.
Publicado: (2016)

Patients with Gaucher disease display systemic oxidative stress dependent on therapy status
por: Kartha, Reena V., et al.
Publicado: (2020)

Monitoring for and Management of Endocrine Dysfunction in Adrenoleukodystrophy
por: Kachwala, Isha, et al.
Publicado: (2022)

Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young Adults
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2021)

Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction
por: Thibert, Kathryn A., et al.
Publicado: (2012)

Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
por: Wang, Hongge, et al.
Publicado: (2022)

A Case of Adrenoleukodystrophy Presenting as Progressive Cerebellar Dysfunction
por: Jung, Seunguk, et al.
Publicado: (2009)

Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson’s disease: a pilot randomized controlled trial
por: Cheung, Corjena, et al.
Publicado: (2018)

Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy
por: Orchard, Paul J., et al.
Publicado: (2019)

ODP310 Early Onset Adrenal Dysfunction in Infants with Adrenoleukodystrophy
por: Patel, Sruti, et al.
Publicado: (2022)

Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease
por: Signorini, Cinzia, et al.
Publicado: (2022)

Docosahexaenoic Acid Attenuates Mitochondrial Alterations and Oxidative Stress Leading to Cell Death Induced by Very Long-Chain Fatty Acids in a Mouse Oligodendrocyte Model
por: Nury, Thomas, et al.
Publicado: (2020)

Post‐transplant adaptive function in childhood cerebral adrenoleukodystrophy
por: Pierpont, Elizabeth I., et al.
Publicado: (2018)

Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy
por: Pierpont, Elizabeth I., et al.
Publicado: (2020)

N-Acetyl-L-cysteine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage: Implications for Age-Related Macular Degeneration
por: Terluk, Marcia R., et al.
Publicado: (2019)

N-Acetylcysteine Reverses Antiretroviral-Mediated Microglial Activation by Attenuating Autophagy-Lysosomal Dysfunction
por: Tripathi, Ashutosh, et al.
Publicado: (2020)

Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014)

Beyond gait and balance: urinary and bowel dysfunction in X-linked adrenoleukodystrophy
por: Corre, Camille S., et al.
Publicado: (2021)

Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy
por: Martinović, Ksenija, et al.
Publicado: (2023)

Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy
por: Gupta, Ashish O., et al.
Publicado: (2021)

N-Acetylcysteine Reverses Cocaine Induced Metaplasticity
por: Moussawi, Khaled, et al.
Publicado: (2009)

Modeling potential interactions between oral Gaucher disease treatment and investigational COVID-19 therapies
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2021)

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2021)

Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy
por: Kakumoto, Toshiyuki, et al.
Publicado: (2023)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Pathophysiology of X-linked adrenoleukodystrophy()
por: Berger, J., et al.
Publicado: (2014)

Multiple sclerosis in an adrenoleukodystrophy carrier
por: Jenkins, Thomas, et al.
Publicado: (2011)

Anesthesia in a child with adrenoleukodystrophy
por: Yang, Hun-Ju, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q1tj32c41rd354c0ka5hj2eve1